Comparative analysis of polystyrene versus zirconia beads on breakage kinetics, heat generation, and amorphous formation during wet bead milling

被引:0
作者
Guner, Gulenay [1 ]
Heidari, Hamidreza [2 ]
Lehman, Kaitlyn [1 ]
Desai, Parind M. [1 ]
Clancy, Donald [1 ]
Bilgili, Ecevit [2 ]
Chattoraj, Sayantan [1 ]
机构
[1] GlaxoSmithKline Res & Dev Ltd, Drug Prod Dev, Med Dev & Supply, Collegeville, PA 19426 USA
[2] New Jersey Inst Technol, Otto H York Dept Chem & Mat Engn, Newark, NJ 07102 USA
关键词
Milling; Processing; Nanoparticles; Suspensions; Mathematical model; Dynamic simulation; Particle sizing; Raman spectroscopy; Amorphous; DRUG NANOSUSPENSIONS; MEDIA; DELIVERY;
D O I
10.1016/j.xphs.2024.11.029
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study determined process conditions under which polystyrene (CPS) and zirconia (YSZ) beads cause similar breakage kinetics and temperature rise during manufacturing of drug nanosuspensions via wet bead milling and explored relative advantages of CPS beads, particularly for stress-sensitive compounds. Besides temperature and particle size measurements, a microhydrodynamic-based kinetic model simulated the conditions for CPS to achieve breakage rates equivalent to those of YSZ. A power law correlation was applied to find conditions conducive to temperature equivalency. The maximum contact pressure and pseudo energy dissipation rate were calculated under these equivalency conditions. When bead loading for CPS was increased to match with YSZ, lower temperature at similar breakage conditions or faster breakage at the same temperature was achieved. Increasing the tip speed did not provide any notable advantages for CPS over YSZ in terms of breakage kinetics or temperature. However, under all conditions investigated, CPS beads exhibited markedly lower maximum contact pressure and pseudo energy dissipation rate, which may correlate with reduced mechanically induced amorphization during milling. A proof-of-concept study demonstrated that a mechanical stress-sensitive drug had lower amorphous generation with CPS compared to YSZ. Therefore, CPS beads are a promising alternative to YSZ beads, especially when used at the highest feasible loading.<br /> (c) 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1175 / 1185
页数:11
相关论文
共 42 条
  • [1] Moschwitzer J.P., Drug nanocrystals in the commercial pharmaceutical development process, Int J Pharm, 453, 1, pp. 142-156, (2013)
  • [2] Peltonen L., Design space and QbD approach for production of drug nanocrystals by wet media milling techniques, Pharmaceutics, 10, 3, (2018)
  • [3] Hennart S.L.A., Domingues M.C., Wildeboer W.J., van Hee P., Meesters G.M.H., Study of the process of stirred ball milling of poorly water soluble organic products using factorial design, Powder Technol, 198, 1, pp. 56-60, (2010)
  • [4] Bauer A., Berben P., Chakravarthi S.S., Et al., Current State and opportunities with long-acting injectables: industry perspectives from the innovation and quality consortium “long-acting injectables” working group, Pharm Res, 7, pp. 1-31, (2023)
  • [5] Salahshoor Z., Desai P.M., Chattoraj S., Lam S., Exploring the relationship between bulk Young's Modulus of materials and milling efficiency during wet bead milling of pharmaceutical compounds, Int J Pharm, 660, (2024)
  • [6] Leng D., Chen H., Li G., Et al., Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size, Int J Pharm, 472, 1, pp. 380-385, (2014)
  • [7] Wei X.-L., Han Y.-R., Quan L.-H., Liu C.-Y., Liao Y.-H., Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation, Eur J Pharm Sci, 49, 2, pp. 286-293, (2013)
  • [8] Kishimoto T., Nitta M., Borenstein M., Kane J.M., Correll C.U., Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies, J Clin Psychiatry, 74, 10, (2013)
  • [9] Winner B., Peipert J.F., Zhao Q., Et al., Effectiveness of long-acting reversible contraception, N Engl J Med, 366, 21, pp. 1998-2007, (2012)
  • [10] Hoffmann C., Llibre J.M., Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors, AIDS Rev, 21, 1, pp. 4-10, (2019)